Initial Inhibition of Tissue Factor Signalling Reduces Chronic Vascular Changes in Isogenic Rat Aortic Transplants

American Journal of Transplantation

Volumn 1, Issue 1, 2001, Pages 29-37

  Österholm, Cecilia ^a   Qi, Zhongquan ^a   Ekberg, Jana ^a   Veress, Béla ^a   Pyke, Charles ^b   Hedner, Ulla ^b   Ekberg, Henrik ^a  

^a LUND UNIVERSITY   (Sweden)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Aorta transplantation; Chronic vasculopathy; Intimal hyperplasia; Ischemia reperfusion injury; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; RECOMBINANT PROTEIN; THROMBOPLASTIN;

ABDOMINAL AORTA; ANIMAL; ARTICLE; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; INTIMA; ISOGRAFT; NECROSIS; PATHOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; TRANSPLANTATION;

ANIMALS; AORTA, ABDOMINAL; FACTOR VIIA; NECROSIS; RATS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANSPLANTATION, ISOGENEIC; TUNICA INTIMA;

EID: 0035342406     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2001.010107.x     Document Type: Article

References (54)

1. Yilmaz S, Paavonen T, Hayry P. Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation 1992; 53: 823-827.
2. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interteukin-2, and interleukin-10. Transplantation 1995; 59: 565-572.
3. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/ reperfusion injury of a single kidney. Transplantation 1997; 64: 190-197.
4. Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 1997; 64: 1102-1107.
5. Connolly JK, Dyer PA, Martin S, Parrott NR, Pearson RC, Johnson RW. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation 1996; 61: 709-714.
6. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
7. Terasaki PI, Cecka JM, Gjertson DW. Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation. In: Cecka JM, Terasaki PI (eds). Clinical Transplant 1998. Los Angeles: UCLA Tissue Typing Laboratory, 1999, pp. 437-441.
8. Tsuchida A, Salem H, Thomson N, Hancock WW. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression. J Exp Med 1992; 175: 81-90.
9. Torry RJ, Labarrere CA, Gargiulo P, Faulk WP. Natural anticoagulant and fibrinolytic pathways in renal allograft failure. Transplantation 1994; 58: 926-931.
10. Wang Y, Pratt JR, Hartley B, Evans B, Zhang L, Sacks SH. Expression of tissue type plasminogen activator and type 1 plasminogen activator inhibitor, and persistent fibrin deposition in chronic renal allograft failure. Kidney Int 1997; 52: 371-377.
11. Torry RJ, Labarrere CA, Nelson D, Carter C, Haag B, Faulk WP. Tubular antithrombin at transplantation determines subsequent renal allograft function. Transplantation 1998; 66: 797-799.
12. Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938.
13. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
14. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
15. + mobilization and protein kinase C activation. J Clin Invest 1993; 91: 547-552.
16. Emofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83: 307-320.
17. Camera M, Giesen PL, Fallon J et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 531-537.
18. Schonbeck U, Mach F, Sukhova GK et al. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 2000; 156: 7-14.
19. Golino P, Ragni M, Cirillo P et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nature Med 1996; 2: 35-40.
20. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest 1990; 85: 1090-1098.
21. Massberg S, Enders G, Matos FC et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999; 94: 3829-3838.
22. Schecter AD, Giesen PL, Taby O et al. Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest 1997; 100: 2276-2285.
23. Bach RR. Mechanism of tissue factor activation on cells. Blood Coagul Fibrinolysis 1998; 9(Suppl. 1): S37-43.
24. Bjorklid E, Storm-Mathisen J, Storm E, Prydz H. Localization of tissue thromboplastin in the human brain. Thromb Haemost 1977; 37: 91-97.
25. Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH. Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 1999; 82: 88-92.
26. Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Sumiyoshi A. Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 1996; 75: 389-392.
27. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140: 1241-1253.
28. Jang Y, Guzman LA, Lincoff AM et al. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 1995; 92: 3041-3050.
29. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89: 2317-2320.
30. Ko FN, Yang YC, Huang SC, Ou JT. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest 1996; 98: 1493-1501.
31. McNamara CA, Sarembock U, Gimple LW, Fenton JW 2d, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-98.
32. Sorensen BB, Freskgard PO, Nielsen LS, Rao LV, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274: 21349-21354.
33. Pendurthi UR, Allen KE, Ezban M, Rao LV. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible down-stream mediators in factor VIIa x tissue factor-induced signal transduction. J Biol Chem 2000; 275: 14632-14641.
34. Camerer E, Rottingen JA, Gjernes E et al. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 1999; 274: 32225-32233.
35. Wanders A, Akyurek ML, Waltenberger J, Ren ZP, Stafberg C, Funa K. Ischemia-induced transplant arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1995; 15: 145-155.
36. Chen J, Akyurek LM, Fellstrom B, Hayry P, Paul LC. Eotaxin and capping protein in experimental vasculopathy. Am J Pathol 1998; 153: 81-90.
37. Sorensen BB, Persson E, Freskgard PO et al. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 1997; 272: 11863-11868.
38. Harker LA, Hanson SR, Wilcox JN, Kelly AB. Antithrombotic and anti-lesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis 1996; 26(Suppl. 1): 76-82.
39. Jacobsson J, Wahlberg J, Frodin L, Odlind B, Tufveson G. Organ flush out solutions and cold storage preservation solutions: effect on organ cooling and post ischemic erythrocyte trapping in kidney grafts. An experimental study in the rat. Scand J Urol Nephrol 1989; 23: 219-222.
40. Gertler JP, Weibe DA, Ocasio VH, Abbott WM. Hypoxia induces procoagulant activity in cultured human venous endothelium. J Vasc Surg 1991; 13: 428-433.
41. Holmberg A, Bergqvist D, Westman B, Siegbahn A. Cytokine and fibrinogen response in patients undergoing open abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 1999; 17: 294-300.
42. Ono K, Matsumori A, Furukawa Y et al. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 1999; 79: 195-203.
43. Schecter AD, Rollins BJ, Zhang YJ et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem 1997; 272: 28568-28573.
44. Mennander A, Paavonen T, Hayry P. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Arterioscler Thromb 1993; 13: 1019-1025.
45. Elm T, Rasmussen K, Ezban M et al. Time course of inactivated-rFVIIa inhibition of tissue factor-rFVIIa activity in a rabbit ex vivo model. Thromb Haemost 1997 (Suppl.): Abstr PS-1652.
46. Giesen PL, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315.
47. Annex BH, Davies MG, Fulton GJ et al. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts. J Surg Res 1998; 80: 164-170.
48. Taylor FB, Chang AC, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood 1998; 91: 1609-1615.
49. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132.
50. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228.
51. Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Kamikubo Y, Sumiyoshi A. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost 1997; 78: 1138-1141.
52. Siegbahn A, Johnell M, Rorsman C et al. Binding of factor VIIa to tissue factor on human fibroblasts leads to inositol-1,4,5-triphosphate release and enhanced PDGF&ndash:BB stimulated chemotaxis. Thromb Haemost 1999 (Suppl.): Abstr PS-1589.
53. Bar-Shavit R, Benezra M, Eldor A et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990; 1: 453-463.
54. Hedner U, Erhardtsen E. Future possibilities in the regulation of the extrinsic pathway: iFVIIa and TFPI. Ann Med 2000; 32 (Suppl. 1): 68-72.